Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Get Out the Rulers—Stunted Dendrites May Flag Early Alzheimer's
14 May 2004. Stunted dendritic arbors in a subpopulation of hippocampal granule cells are an early sign of Aβ-induced damage, according to a new study of transgenic PDAPP mice in the May 4 PNAS. The authors suggest that this pathology, which pre-dates amyloid deposition, might serve as a useful marker of the efficacy of any future treatments.

Last year, Floyd Bloom and colleagues published an imaging study of early hippocampal volume changes in the PDAPP mouse (see ARF related news story). Bloom is a cofounder of the biotech firm Neurome in La Jolla, California, and the current study was produced in collaboration with Elan Pharmaceuticals, which holds the patent to the PDAPP mouse. In the present article Bloom, first author Chi-Cheng Wu and their colleagues focused on PDAPP mice at 90 days, an age at which their previous study had already found significant hippocampal volume loss, especially in the granule cell (GC) layers of the dentate gyrus (DG) and the molecular layer, into which the GCs spread their dendrites.


Dendritic morphology of dentate granule cell (GC) subtypes bewteen Tg and nTg mice. Note: Superficially located GC (SGC) of Tg mice exhibited a significant reduction in dendritic trees in compraison with that of nTg mice, while no difference was foun in DGC of both groups of mice. Arrows: Dendritic truncations in mid-to-outer molecular layers (MML and OML) of the dentate gyrus. [GCL: granule cell layer; IML: inner molecular layer] Photo Credit: Chi-Cheng Wu et al., Neurome Inc.

The study takes advantage of technologies that would have dazzled Santiago Ramón y Cajal. The grandfather of neurobiology labored with Camillo Golgi's temperamental silver staining techniques in order to produce his exquisite drawings of neurons at the turn of the 20th century. Until recently, the only technique that has made any claim to challenging the Golgi stain is the tricky, labor-intensive process of poking individual cells to inject horseradish peroxidase or fluorescent dyes.

In recent years, a simple new tool has emerged—the gene gun that blasts gold particles encrusted with DNA or RNA into cells. Dyes can also be attached to the gold and thus delivered to large numbers of cells when the helium blast forces the particles through cell membranes. The lipophilic dyes are transported throughout the cell, including into the dendritic arbors.

Wu and colleagues bombarded hippocampal slices with the fluorescent dye DiI, and then reconstructed 3-D images of randomly selected granule cells of the dentate gyrus. (Their methodology is described in a separate article in the May issue of Cerebral Cortex.) Quantitative analysis of the dendritic arbors of these cells showed a 12 percent reduction in total dendritic length in the PDAPP mice relative to control littermates. Several subsets of cells had even greater dendritic reductions—23 percent for cells in the dorsal blade of the DG, and 32 percent for superficial cells in the posterior GC. Among the latter, the dendritic reduction took place in the middle to outer portions of the molecular layer.

The results support the proposition that early changes occur in the hippocampus long before amyloid deposition takes place, at least in familial AD. The authors suggest these changes could form the basis of assays that can be used in testing the effects of proposed drugs in PDAPP mice.—Hakon Heimer.

References:
Wu CC, Chawla F, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE. Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: Digital morphometric analyses. Proc Natl Acad Sci U S A. 2004 May 4;101(18):7141-6. Epub 2004 Apr 26. Abstract

Wu CC, Reilly JF, Young WG, Morrison JH, Bloom FE. High-throughput Morphometric Analysis of Individual Neurons. Cereb Cortex. 2004 May;14(5):543-54. Epub 2004 Mar 28. Abstract

 
Comments on News and Primary Papers
  Comment by:  Mary Reid
Submitted 31 May 2004  |  Permalink Posted 7 June 2004

Is Cdc42 expressed in these cell types displaying dendritic reductions in the PDAPP mice? Scott et al. (1) find that Cdc42 mutant VS neurons display increased dendritic length. Zhu et al. (2) find that Cdc42 is upregulated in select neuronal populations in AD. Might it suggest that this upregulation may explain reduced dendritic length in AD?

References:
(1) Scott EK, Reuter JE, Luo L. Small GTPase Cdc42 is required for multiple aspects of dendritic morphogenesis. J Neurosci. 2003 Apr 15;23(8):3118-23. Abstract

(2) Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA. Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):433-7. Abstract

View all comments by Mary Reid

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad